9:23 AM
Leo Group India
| ||
| Pharmaceutical industry agrees to enforcement of marketing code: Indian ... Economic Times Pharma industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe medicines. See all stories on this topic » | ||
| Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals MarketWatch (press release) To support the delivery of value-based care, the National Pharmaceutical Council (NPC), the American Medical Group Association (AMGA) and the Premier health care alliance teamed with seven provider organizations to form the Working Group on ... See all stories on this topic » | ||
| Pharma industry agrees to enforcement of marketing code Business Standard The pharmaceutical industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe their medicines, according to Indian Pharmaceutical Alliance (IPA). "We have expressed our ... See all stories on this topic » | ||
| EnVivo Pharmaceuticals Announces Statistically Significant Improvement in ... MarketWatch (press release) WATERTOWN, Mass., Jul 18, 2012 (BUSINESS WIRE) -- EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced positive results from its Phase 2b clinical trial of ... See all stories on this topic » | ||
| Dr Reddy's bets big on biosimilars, eyes regulated markets Economic Times Hyderabad-based Dr Reddy's Laboratories is betting big on the biosimilars segment and expects to enter developed markets soon. See all stories on this topic » | ||
| Lexicon Pharmaceuticals and Rosetta Genomics Showing Impressive Growth in ... MarketWatch (press release) According to a Pharmaceuticals & Biotechnology report from IMAP, several pharmaceutical firms have altered their drug portfolios from primary care driven blockbusters towards specialties such as oncology, immunology and inflammation, where the medical ... See all stories on this topic » | ||
| Law Firm Brower Piven Announces Investigation in Connection With Par ... MarketWatch (press release) On July 16, 2012, Par Pharmaceutical announced that it had entered into a definitive merger agreement to be acquired by an affiliate of TPG in a transaction with an equity value of $1.9 billion. Under the terms of the buyout transaction, Par ... See all stories on this topic » | ||
| Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation ... MarketWatch (press release) SAN DIEGO, Jul 17, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements with Mylan Inc. and its subsidiary ... See all stories on this topic » | ||
| MedPro signs letter of intent with specialty pharmaceutical co for licensing ... pharmabiz.com MedPro signs letter of intent with specialty pharmaceutical co for licensing its drug delivery platform. See all stories on this topic » | ||
| Somaxon keeps insomnia drug exclusivity till 2020 Reuters India (Reuters) - Somaxon Pharmaceuticals Inc protected the market exclusivity for its insomnia treatment till 2020 by settling separate patent lawsuits with Mylan Pharmaceuticals and Par Pharmaceutical Cos. See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment